/PRNewswire/ As an organization that generates regulatory-endorsed solutions and methodologies to accelerate drug development, Critical Path Institute.
/PRNewswire/ Critical Path Institute (C-Path) today named Daniel M. Jorgensen, M.D., MPH, MBA, its Chief Executive Officer (CEO). An experienced leader in.
/PRNewswire/ Critical Path Institute (C-Path) has announced it will serve as the convener of the Critical Path for Rare Neurodegenerative Diseases (CP-RND),.